MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Neil S who wrote (1072)	7/16/1998 12:37:00 PM
From: seminole	of 1826

Neil <<Total sales were $3.26 million in the quarter, up from $2.00 million a year ago. MGI posted break-even earnings per share, up from a year ago when it lost $0.06 a share.>>> I have always used revenue growth as a stock selection tool. As revenues grow so do economies of scale and earnings. Wall Street MBAs tend to concern themselves with current cash flow and a discounted flow of future cash. I watch revenues and competition that could lead to margin changes, and seem to stay one step ahead of the crowd. Oh, and I like the drug too richard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next